The KiTZ is developing new diagnostic and therapeutic procedures to combat childhood cancer. This is only possible if research and clinic work hand in hand. To ensure this, the KiTZ is divided into three programs: clinical, translational and preclinical. As soon as the planned new building for the KiTZ has been erected, these areas of the KiTZ can move even closer together.
For more information on the KiTZ programs...
... please click the info graphic:
The KiTZ program I "Clinical Pediatric Oncology" (headed by Prof. Dr. Andreas Kulozik) covers outpatient, day-clinic and in-patient clinical care as well as conducting clinical trials for our patients with cancer and severe blood diseases.
Leukemia: Novel approaches for treatment in close cooperation with the research group Muckenthaler
Osteosarcoma: Novel strategies of medicinal and local theraphy
(see also: OSCAR heavy ion therapy)
Hemoglobin dieseases: Novel treatment concepts for patients suffering from thalassemia and sickle cell disease in the "Thalassemia and Sickle Cell Center Rhein-Neckar"
+49 6221 564500
andreas.kulozik(at)med.uni-heidelberg.de
Postal address:
Clinic for Pediatric Oncology, Hematology, and Immunology
Center for Child and Adolescent Medicine
Jutta Mattern
Im Neuenheimer Feld 430
D-69120 Heidelberg
Germany
The KiTZ program II "Translational Pediatric Oncology" (headed by Prof. Dr. Olaf Witt) comprises innovative individualized forms of treatment for children with malignant diseases. The focus is on the translation of new research findings into early clinical trials - especially for patients who did not benefit from established therapies. For this purpose, a study unit was set up at the KiTZ, the "KiTZ Clinical Trial Unit". There, young patients get access to new, targeted treatment options.
+49 6221 423570
o.witt(at)kitz-heidelberg.de
Postal address:
German Cancer Research Center
CCU Pediatric Oncology / G340
Nicola Herrmann-Wichmann
Im Neuenheimer Feld 280
D-69120 Heidelberg
Germany
The KiTZ program III "Preclinical Pediatric Oncology" (headed by Prof. Dr. Stefan Pfister) combines experimental pediatric oncology research groups from the DKFZ and the University Hospital. The aim is to develop new diagnostic methods for the classification of tumor diseases, to identify new mechanisms of tumorigenesis, and to derive therapeutic approaches from them. The researchers of the KiTZ pay particular attention to the identification and characterization of new genetic and epigenetic structures that could be associated with the development of childhood cancers. These will be used as targets for drug therapies or as diagnostic targets.
+49 6221 424617
s.pfister(at)kitz-heidelberg.de
Postal address:
German Cancer Research Center
Div. Pediatric Neurooncology / B062
Ines Hofmann
Im Neuenheimer Feld 580
D-69120 Heidelberg
Germany
